Cargando…

Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 – CORRIGENDUM

Detalles Bibliográficos
Autores principales:	Lee Wilkinson, Anna, Pedrana, Alisa, Traeger, Michael W, Asselin, Jason, El-Hayek, Carol, Nguyen, Long, Polkinghorne, Victoria, Doyle, Joseph S, Thompson, Alexander J, Howell, Jessica, Scott, Nick, Dimech, Wayne, Guy, Rebecca, Hellard, Margaret, Stoové, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895719/ https://www.ncbi.nlm.nih.gov/pubmed/35241187 http://dx.doi.org/10.1017/S0950268822000310

Ejemplares similares

Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019
por: Lee Wilkinson, Anna, et al.
Publicado: (2021)

The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services
por: Traeger, Michael W., et al.
Publicado: (2020)

Australia needs to increase testing to achieve hepatitis C elimination
por: Scott, Nick, et al.
Publicado: (2020)

Affordable treatment and political commitment are crucial to eliminate hepatitis C globally
por: Hellard, Margaret, et al.
Publicado: (2021)

Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs
por: Traeger, Michael W., et al.
Publicado: (2022)

Letter to the Editor: Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective
por: Harney, Brendan, et al.
Publicado: (2020)

Hepatitis C risk perceptions and attitudes towards reinfection among HIV‐diagnosed gay and bisexual men in Melbourne, Australia
por: Schroeder, Sophia E, et al.
Publicado: (2019)

Eliminating hepatitis C virus as a public health threat among HIV‐positive men who have sex with men: a multi‐modelling approach to understand differences in sexual risk behaviour
por: Scott, Nick, et al.
Publicado: (2018)

Pathology Laboratory Surveillance in the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections and Blood-Borne Viruses: Protocol for a Cohort Study
por: van Gemert, Caroline, et al.
Publicado: (2019)

Monitoring the Control of Sexually Transmissible Infections and Blood-Borne Viruses: Protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS)
por: Callander, Denton, et al.
Publicado: (2018)

The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia
por: Gunn, Jack, et al.
Publicado: (2023)

Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: a mixed-methods evaluation of the Tasmanian Eliminate Hepatitis C Australia Outreach Project, 2020–2022
por: Dawe, Joshua, et al.
Publicado: (2023)

Corrigendum in “Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C”
por: Pavan, Maria Helena Postal, et al.
Publicado: (2013)

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
por: Scott, Nick, et al.
Publicado: (2018)

Hepatitis C Virus Reactivation Following COVID-19 Vaccination – A Case Report [Corrigendum]
Publicado: (2021)

Assessment of service refinement and its impact on repeat HIV testing by client's access to Australia's universal healthcare system: a retrospective cohort study
por: Ryan, Kathleen E, et al.
Publicado: (2019)

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
Publicado: (2019)

Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions
por: Wallace, Jack, et al.
Publicado: (2022)

Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis
por: Traeger, Michael W, et al.
Publicado: (2023)

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
por: Scott, Nick, et al.
Publicado: (2019)

A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C
por: Ramsay, Jessica, et al.
Publicado: (2020)

Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study
por: Scott, Dr Nick, et al.
Publicado: (2021)

Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study)
por: O’Keefe, Daniel, et al.
Publicado: (2022)

Pathways to ensure universal and affordable access to hepatitis C treatment
por: Douglass, Caitlin H., et al.
Publicado: (2018)

Corrigendum: A novel substitution in NS5A enhances resistance of hepatitis C virus genotype 3 to daclatasvir
por: Fernandes Campos, Guilherme Rodrigues, et al.
Publicado: (2021)

A global investment framework for the elimination of hepatitis B
por: Howell, Jessica, et al.
Publicado: (2021)

Aiming towards hepatitis C virus elimination in Greece
por: Papatheodoridis, George V., et al.
Publicado: (2019)

Hepatitis C virus elimination: time for disruptive innovation
por: Klein, Marina B
Publicado: (2019)

Perspectives of hepatitis C virus (HCV) elimination in Poland
por: Flisiak, Robert, et al.
Publicado: (2019)

Daclatasvir: potential role in hepatitis C [Corrigendum]
Publicado: (2014)

Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis
por: Lim, Aaron G., et al.
Publicado: (2021)

Corrigendum to “Transmission Model of Hepatitis B Virus with the Migration Effect”
por: Khan, Muhammad Altaf, et al.
Publicado: (2016)

Corrigendum to “An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients”
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Corrigendum: Direct-acting antiviral agents in Hepatitis C Virus infected renal allograft recipients: Treatment and outcome experience from single center
Publicado: (2018)

Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum]
Publicado: (2021)

Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients
por: Draper, Bridget, et al.
Publicado: (2022)

High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
por: Sacks-Davis, Rachel, et al.
Publicado: (2013)

Queer as F**k: Reaching and Engaging Gay Men in Sexual Health Promotion through Social Networking Sites
por: Pedrana, Alisa, et al.
Publicado: (2013)

Time-to-hepatitis C treatment initiation among people who inject drugs in Melbourne, Australia
por: Aung, Phyo T. Z., et al.
Publicado: (2023)

Corrigendum: RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7d92jbgqvq73cn90kf4iap0oui